Abstract
The pathophysiological process of intracerebral hemorrhage (ICH) is very complex, involving various mechanisms such as apoptosis, oxidative stress and inflammation. As one of the key factors, the inflammatory response is responsible for the pathological process of acute brain injury and is associated with the prognosis of patients. Abnormal or dysregulated inflammatory responses after ICH can aggravate cell damage in the injured brain tissue. The NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome is a multiprotein complex distributed in the cytosol, which can be triggered by multiple signals. The NLRP3 inflammasome is activated after ICH, thus promoting neuroinflammation and aggravating brain edema. In addition, there is evidence that the gut microbiota is crucial in the activation of the NLRP3 inflammasome. The gut microbiota plays a key role in a variety of CNS disorders. Changes in the diversity and species of the gut microbiota affect neuroinflammation through the activation of the NLRP3 inflammasome and the release of inflammatory cytokines. In turn, the gut microbiota composition can be influenced by the activation of the NLRP3 inflammasome. Thereby, the regulation of the microbe–gut–brain axis via the NLRP3 inflammasome may serve as a novel idea for protecting against secondary brain injury (SBI) in ICH patients. Here, we review the recent evidence on the functions of the NLRP3 inflammasome and the gut microbiota in ICH, as well as their interactions, during the pathological process of ICH.
Funder
National Natural Science Foundation of China
Shandong Provincial Natural Science Foundation of China
China Postdoctoral Science Foundation
Subject
Food Science,Nutrition and Dietetics
Reference63 articles.
1. Stages of the Inflammatory Response in Pathology and Tissue Repair after Intracerebral Hemorrhage;Askenase;Semin. Neurol.,2016
2. Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets;Tschoe;J. Stroke,2020
3. The NLRP3-inflammasome as a sensor of organelle dysfunction;Seoane;J. Cell Biol.,2020
4. NLRP3 Inflammasome: A Potential Alternative Therapy Target for Atherosclerosis;Liu;Evid.-Based Complement. Altern. Med. Ecam,2020
5. Wani, K., AlHarthi, H., Alghamdi, A., Sabico, S., and Al-Daghri, N.M. (2021). Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders. Int. J. Environ. Res. Public Health, 18.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献